Droxidopa in Critical Care: A Systematic Review of an Emerging Off‐Label Practice
Carlos Valladares, Franklyn Vega Batista, Marc Faltas, Mareya Menteyas, Katherine Chiapaikeo-Poco · 2025
Read Droxidopa in Critical Care: A Systematic Review of an Emerging Off‐Label Practice by Carlos Valladares, Franklyn Vega Batista, Marc Faltas, Mareya Menteyas, Katherine Chiapaikeo-Poco (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714080.txt.
Description
Carlos Valladares and four co-authors sum what is known on droxidopa, a blood-press drug, used off-label in intensive care. Their review appeared in twenty twenty-five. Long drip drugs to hold blood press bring harm, and droxidopa is cleared for a nerve-based press drop on standing. The team swept four bases through April twenty twenty-five for real patient data on its ICU use to wean drips.
Seven small past-look works held one hundred sixty-one patients in all. Time to drip stop ran from one day to five. ICU stay ran long where told. The team call the proof thin and mixed, and urge more and stricter work.
Catalog record
| CREATOR | Carlos Valladares, Franklyn Vega Batista, Marc Faltas, Mareya Menteyas, Katherine Chiapaikeo-Poco |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |